PharmiWeb.com - Global Pharma News & Resources
14-Jan-2022

Oxytocin Market : Value Chain, Stakeholder Analysis and Trends by 2030

ESOMAR certified consulting firm Future Market Insights (FMI) has recently published an exhaustive yet unbiased report on the global oxytocin market, highlighting the prominent parameters responsible for steering growth in the long-run. The study opines global oxytocin sales to grow at over 8% through 2030, with growing focus on preventing PPH incidences expected to drive demand.

While the frequency of childbirths is increasing, the number of complications faced by women are also compounding. The Center for Disease Control and Prevention estimates that over 50,000 women across the U.S endure life-threatening complications.

Consequently, healthcare providers are incorporating solutions aimed at reducing trauma faced by patients which include numerous approaches. A common complication faced by women is postpartum hemorrhage, for which oxytocin treatment is a highly preferred option. A value CAGR exceeding 8% is projected for the market through 2030.

Key Takeaways

  • Postpartum hemorrhage (PPH) solutions to comprise nearly 90% of the revenue share in 2020 by product type
  • Hospital pharmacies remain key distribution channels, online pharmacies’ popularity to widen
  • Opportunities abound across the Middle East & Africa (MEA) owing to rising PPH incidence in Africa
  • Global oxytocin market is projected to reach US$ nearly US$ 165 Mn by 2030

Request The Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11218

“Government initiatives to promote women and children’s health are bolstering global efforts to improve maternity care across healthcare settings, thereby opening significant growth avenues for the global oxytocin market,” comments the FMI analyst.

COVID-19 Impact Analysis

As the COVID-19 pandemic intensified, the global medical fraternity is facing immense challenges as resources are being redirected towards eradicating the deadly virus. Consequently, other treatment areas have been relegated to the backseat, including maternity care. This is a cause of concern amongst leading healthcare specialists.

Therefore, efforts are being made towards ensuring adequate and proper treatment to pregnant women across all regions. Furthermore, oxytocin has also been touted as an effective anti-viral agent, thus raising optimism that it could be effectively leveraged to promote drug or vaccine development.

The National Center for Biotechnology Information hypothesizes that oxytocin contains dipeptidyl peptidase-4 (DPP4) protease inhibitors could be effective against the existing novel coronavirus strain. It further propagates that enhancing endogenous oxytocin levels could increase viral resistance and improve health of vulnerable groups.

Competitive Landscape

Prominent players in the global oxytocin market include Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International Plc. (Par Sterile Products, LLC), Teva Pharmaceuticals Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd. and Yuhan Corporation.

The market is highly fragmented, peppered with numerous regional and global level market players. These players largely concentrate on forging strategic collaborations with existing players, regional distributors, product launches and acquisitions. Most players are concentrating on offering anesthetic oxytocin solutions to reduce labor induced complications for C-section operations.

More Insights on FMI’s Oxytocin Market Report

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The study provides compelling insights on oxytocin market on the basis of indication (antepartum and postpartum) and distribution channel (hospital pharmacies, retail pharmacies, drug stores and online pharmacies) across seven major regions.

Speak To Analyst about queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-11218

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
  • Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape

General Anesthesia Drugs Market – A recent market study published by FMI on the general anesthesia drugs market during 2014-2018 & forecast for 2019-2029 offers a comprehensive assessment of the most important market dynamics.

Companion Animal Drugs Market – A recent market study published by Future Market Insights on the companion animal drugs market includes global industry analysis 2014-2018 & opportunity assessment 2019-2029

Prophylactic HIV drugs Market – Prophylactic HIV drugs Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries:
 press@futuremarketinsights.com
Website:
 https://www.futuremarketinsights.com/

Editor Details

Last Updated: 14-Jan-2022